An open-label, multi-center, phase I/II study to assess safety, disease progression, and cellular kinetics following YTB323 administration in participants with non-active Progressive Multiple Sclerosis (PMS)

Project: Research

Project Details

StatusActive
Effective start/end date18/11/24 → 2/05/28

Keywords

  • clinical trial
  • Multiple Sclerosis
  • PMS

Clinical Trial Phase

  • Phase II
  • Phase I